C-I3WFCyclarity Therapeutics
cyclodextrins, cholesterol clearance, plaque removal
clearingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-I3WF
C-I3WFC-I3WFcyclodextrins, cholesterol clearance, plaque removal
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Cyclarity Therapeutics states that age-related diseases, especially atherosclerosis, can be treated by addressing their underlying cause rather than only managing symptoms. The company’s stated belief is that toxic, non-degradable cholesterol accumulates within cells in arterial walls, drives plaque buildup, and can be cleared using simple, direct, rationally designed drugs based on novel derivatives of safe cyclodextrin compounds, enabling disease-modifying and potentially preventive therapies.
SourceCyclarity Therapeutics states that common age-related diseases, especially atherosclerosis, are driven by underlying damage from arterial plaque buildup caused by non-degradable cholesterol accumulating inside cells in arterial walls, and that this damage can be directly repaired with simple, rationally designed, easy-to-use drugs based on novel cyclodextrin derivatives. The company presents its approach as a root-cause, disease-modifying strategy intended not just to manage symptoms but to treat, cure, and reverse atherosclerosis and eventually provide affordable preventive therapies for multiple age-related diseases.
SourceCyclarity states that age-related diseases can be treated by addressing their underlying damage rather than only managing symptoms. It argues that atherosclerosis and related conditions are driven by the buildup of arterial plaque, especially non-degradable toxic cholesterol accumulating inside cells in arterial walls, and that simple, direct, rationally designed drugs based on cyclodextrin derivatives can clear this material, modify disease progression, and ultimately help treat, cure, or reverse age-related disease.
Source